Menu
Not yet recruiting NCT07722273

Immediate Effects of Pogo Jumps on Vertical Jump Performance in Young Basketball Players

No phase Interventional Post-activation Performance Enhancement

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: POGO-JUMP, CONTROL.
Who it may be relevant to
Registry conditions: Post-activation Performance Enhancement. Basic parameters: 15 years — 18 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Immediate Effects of a Pogo-Jump Microdose on Vertical Jump Performance in Adolescent Basketball Players: A Randomized Crossover Pilot Study

Overview

This study aims to examine the acute effects of a low-volume bilateral pogo jump protocol on CMJ and DJ performance, as well as its feasibility and immediate tolerance in adolescent male basketball players.

Detailed description

This study aims to investigate whether a low-volume bilateral pogo jump protocol can induce post-activation performance enhancement (PAPE) in adolescent male basketball players. Using a randomized crossover design, participants will complete both a pogo jump intervention and a light walking control condition, with countermovement jump (CMJ) and drop jump (DJ) performance assessed before and one minute after each condition. The study will also evaluate the immediate tolerance and field feasibility of this microdose plyometric protocol.

Interventions

  • Other POGO-JUMP
    Participants will perform 3 sets of 8 consecutive bilateral pogo jumps (24 ground contacts in total), with 1 min of passive recovery between sets. They will be instructed to jump with maximal intent, minimize ground contact time, and maintain relative knee extension while avoiding a deep countermovement.
  • Other CONTROL
    Participants will walk continuously at a comfortable, low intensity for approximately 3 min, without running, jumping, or abrupt changes of pace.

Primary outcome measures

  • Countermovement jump (CMJ) height (cm) [Time frame: Baseline and immediately after the intervention]
  • Drop jump (DJ) height (cm) [Time frame: Baseline and immediately after the intervention]

Eligibility criteria

Inclusion criteria

  • Regular structured basketball training.
  • Ability to understand instructions.
  • Safe execution of the jump tests after familiarization.
  • Written informed consent from a parent or legal guardian, and assent from the minor.

Exclusion criteria

  • Acute injury limiting participation.
  • Lower-limb pain aggravated by jumping.
  • Recent surgery or a relevant health condition.
  • Inability to perform the test technique safely.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Single blind
Primary purpose
Other

Study locations

Spain · 1 center
  • University Cardenal Herrera — Alfara del Patriarca

Identifiers

NCT: NCT07722273 · UNIVERSITY CARDENAL HERRERA-56

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗